News

Facio partners with Evotec and initiates FSHD drug discovery programme.

Courtagen Life Sciences, Inc have announced the release of a NGS test focused on detection of anti-epileptic drug (AED) compatibilities and interactions for patients receiving treatment for epilepsy or other seizure disorders.

Cardiff University scientists discover compound capable of fighting cancer on multiple fronts.

Results have been published of a multi-center phase I/II study of the investigational anti-cancer agent rociletinib in patients with EGFR-mutant non-small cell lung cancer (NSCLC) that had progressed after previous treatment with EGFR inhibitors.

Agreement pairs mass spectrometry and biomedical science expertise to open new doors for health.

A review in the Annals of Pharmacotherapy has examined the literature on alternative routes of administration for antipsychotic and antidepressant medications.

New research suggests it may be possible to predict an infant’s progress following surgery for congenital heart disease by analysing a number of important small molecules in the blood.

Dr. Scherer will receive the prestigious Medal for diabetes research.

The demand for ever more information by the genomics field began about two decades ago with the advent of microarray technology and has grown exponentially ever since.

Evidence continues to surface that supports the premise that antibiotics which have been out of use could still be effective in treating drug-resistant bacteria.